nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—enteric nervous system—ulcerative colitis	0.378	0.499	CbGeAlD
Cyamemazine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.287	0.378	CbGeAlD
Cyamemazine—Fluphenazine—CALM3—ulcerative colitis	0.0375	0.166	CrCbGaD
Cyamemazine—Promethazine—CALM3—ulcerative colitis	0.0304	0.135	CrCbGaD
Cyamemazine—Trifluoperazine—CALM3—ulcerative colitis	0.03	0.133	CrCbGaD
Cyamemazine—Perphenazine—CALM3—ulcerative colitis	0.0297	0.132	CrCbGaD
Cyamemazine—HTR2A—epithelium—ulcerative colitis	0.0285	0.0376	CbGeAlD
Cyamemazine—HTR2A—smooth muscle tissue—ulcerative colitis	0.0275	0.0362	CbGeAlD
Cyamemazine—Chlorpromazine—CALM3—ulcerative colitis	0.0235	0.104	CrCbGaD
Cyamemazine—HTR2A—digestive system—ulcerative colitis	0.0217	0.0286	CbGeAlD
Cyamemazine—HTR2A—liver—ulcerative colitis	0.0162	0.0213	CbGeAlD
Cyamemazine—Imipramine—SLC22A4—ulcerative colitis	0.0131	0.0583	CrCbGaD
Cyamemazine—Diltiazem—ABCB1—ulcerative colitis	0.00611	0.0271	CrCbGaD
Cyamemazine—Triflupromazine—ABCB1—ulcerative colitis	0.00545	0.0242	CrCbGaD
Cyamemazine—Acepromazine—ALB—ulcerative colitis	0.00528	0.0234	CrCbGaD
Cyamemazine—Thioproperazine—ALB—ulcerative colitis	0.00516	0.0229	CrCbGaD
Cyamemazine—Pipotiazine—ALB—ulcerative colitis	0.00508	0.0225	CrCbGaD
Cyamemazine—Fluphenazine—ABCB1—ulcerative colitis	0.00419	0.0186	CrCbGaD
Cyamemazine—Clomipramine—ALB—ulcerative colitis	0.00401	0.0178	CrCbGaD
Cyamemazine—Clomipramine—ABCB1—ulcerative colitis	0.00383	0.017	CrCbGaD
Cyamemazine—Chlorprothixene—ABCB1—ulcerative colitis	0.00381	0.0169	CrCbGaD
Cyamemazine—Trimipramine—ABCB1—ulcerative colitis	0.00353	0.0156	CrCbGaD
Cyamemazine—Promethazine—ABCB1—ulcerative colitis	0.00339	0.0151	CrCbGaD
Cyamemazine—Trifluoperazine—ABCB1—ulcerative colitis	0.00335	0.0149	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—ulcerative colitis	0.00275	0.0122	CrCbGaD
Cyamemazine—Chlorpromazine—ABCB1—ulcerative colitis	0.00263	0.0117	CrCbGaD
Cyamemazine—Imipramine—ABCB1—ulcerative colitis	0.00261	0.0116	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Other—CXCR1—ulcerative colitis	0.000279	0.0179	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000264	0.0169	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000259	0.0166	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—CXCR2—ulcerative colitis	0.000223	0.0143	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—CXCR2—ulcerative colitis	0.000219	0.014	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000162	0.0104	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000159	0.0102	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—GNA12—ulcerative colitis	0.000155	0.00997	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000142	0.00913	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—ADRB2—ulcerative colitis	0.00014	0.00895	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—ADRB2—ulcerative colitis	0.000137	0.00879	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.000131	0.00838	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000124	0.00793	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000122	0.00782	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000121	0.00778	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CCL20—ulcerative colitis	0.000115	0.00736	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000111	0.00714	CbGpPWpGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000109	0.007	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000108	0.00693	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000107	0.00686	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000106	0.00679	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000105	0.00671	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000104	0.00667	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.000102	0.00656	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	9.77e-05	0.00626	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	9.67e-05	0.0062	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CCR6—ulcerative colitis	9.62e-05	0.00617	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—CD14—ulcerative colitis	9.6e-05	0.00616	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	9.54e-05	0.00612	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	9.5e-05	0.00609	CbGpPWpGaD
Cyamemazine—HTR2A—G alpha (q) signalling events—GHRL—ulcerative colitis	9.48e-05	0.00608	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	9.3e-05	0.00596	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCR1—ulcerative colitis	9.29e-05	0.00595	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	9.24e-05	0.00593	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	9.22e-05	0.00591	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	9.13e-05	0.00585	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	9.09e-05	0.00583	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	8.97e-05	0.00575	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	8.93e-05	0.00572	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	8.48e-05	0.00544	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	8.29e-05	0.00531	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCL20—ulcerative colitis	8.15e-05	0.00523	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	8.14e-05	0.00522	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCR1—ulcerative colitis	8.06e-05	0.00517	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL10—ulcerative colitis	8.02e-05	0.00514	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	8.01e-05	0.00513	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCR1—ulcerative colitis	7.92e-05	0.00508	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	7.9e-05	0.00506	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL10—ulcerative colitis	7.87e-05	0.00505	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	7.86e-05	0.00504	CbGpPWpGaD
Cyamemazine—CHRM2—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	7.85e-05	0.00503	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	7.79e-05	0.005	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	7.65e-05	0.0049	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCR2—ulcerative colitis	7.27e-05	0.00466	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	7.23e-05	0.00464	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCL20—ulcerative colitis	7.08e-05	0.00454	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	6.99e-05	0.00448	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCL20—ulcerative colitis	6.95e-05	0.00446	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	6.86e-05	0.0044	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCR6—ulcerative colitis	6.83e-05	0.00438	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	6.74e-05	0.00432	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCR2—ulcerative colitis	6.31e-05	0.00405	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	6.28e-05	0.00403	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCR2—ulcerative colitis	6.2e-05	0.00397	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	6.17e-05	0.00395	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	6.07e-05	0.00389	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—PTGER4—ulcerative colitis	6.02e-05	0.00386	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.99e-05	0.00384	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.96e-05	0.00382	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCR6—ulcerative colitis	5.93e-05	0.0038	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCR6—ulcerative colitis	5.83e-05	0.00374	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—GHRL—ulcerative colitis	5.51e-05	0.00353	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—ADCY5—ulcerative colitis	5.45e-05	0.00349	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCR1—ulcerative colitis	5.25e-05	0.00336	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—PTGER4—ulcerative colitis	5.22e-05	0.00335	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.2e-05	0.00333	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—PTGER4—ulcerative colitis	5.13e-05	0.00329	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.1e-05	0.00327	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—GHRL—ulcerative colitis	4.78e-05	0.00307	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCR1—ulcerative colitis	4.77e-05	0.00306	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—GHRL—ulcerative colitis	4.7e-05	0.00301	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCL20—ulcerative colitis	4.61e-05	0.00295	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRB2—ulcerative colitis	4.56e-05	0.00292	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCR1—ulcerative colitis	4.56e-05	0.00292	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCR1—ulcerative colitis	4.47e-05	0.00287	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	4.38e-05	0.00281	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GNA12—ulcerative colitis	4.33e-05	0.00278	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	4.3e-05	0.00276	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	4.28e-05	0.00274	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	4.2e-05	0.0027	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL20—ulcerative colitis	4.18e-05	0.00268	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCR1—ulcerative colitis	4.14e-05	0.00265	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	4.13e-05	0.00265	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCR2—ulcerative colitis	4.11e-05	0.00263	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCR1—ulcerative colitis	4.06e-05	0.00261	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCL20—ulcerative colitis	4e-05	0.00257	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRB2—ulcerative colitis	3.96e-05	0.00254	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GNA12—ulcerative colitis	3.93e-05	0.00252	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCL20—ulcerative colitis	3.93e-05	0.00252	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	3.92e-05	0.00251	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRB2—ulcerative colitis	3.89e-05	0.00249	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCR6—ulcerative colitis	3.86e-05	0.00248	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	3.85e-05	0.00247	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GNA12—ulcerative colitis	3.76e-05	0.00241	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCR2—ulcerative colitis	3.73e-05	0.00239	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	3.72e-05	0.00238	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GNA12—ulcerative colitis	3.69e-05	0.00237	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL20—ulcerative colitis	3.63e-05	0.00233	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL20—ulcerative colitis	3.57e-05	0.00229	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.57e-05	0.00229	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCR6—ulcerative colitis	3.51e-05	0.00225	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCR2—ulcerative colitis	3.5e-05	0.00225	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SEL1L—ulcerative colitis	3.42e-05	0.00219	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GNA12—ulcerative colitis	3.42e-05	0.00219	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PTGER4—ulcerative colitis	3.4e-05	0.00218	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GNA12—ulcerative colitis	3.35e-05	0.00215	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCR6—ulcerative colitis	3.35e-05	0.00215	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCR6—ulcerative colitis	3.29e-05	0.00211	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCR2—ulcerative colitis	3.24e-05	0.00208	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCR2—ulcerative colitis	3.18e-05	0.00204	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GHRL—ulcerative colitis	3.11e-05	0.002	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.1e-05	0.00199	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PTGER4—ulcerative colitis	3.09e-05	0.00198	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3.05e-05	0.00196	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR6—ulcerative colitis	3.04e-05	0.00195	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3e-05	0.00192	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR6—ulcerative colitis	2.99e-05	0.00192	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SEL1L—ulcerative colitis	2.97e-05	0.0019	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.95e-05	0.00189	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SEL1L—ulcerative colitis	2.91e-05	0.00187	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PTGER4—ulcerative colitis	2.9e-05	0.00186	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.89e-05	0.00185	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GHRL—ulcerative colitis	2.83e-05	0.00181	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCR1—ulcerative colitis	2.82e-05	0.00181	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CALM3—ulcerative colitis	2.74e-05	0.00176	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GHRL—ulcerative colitis	2.7e-05	0.00173	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PTGER4—ulcerative colitis	2.68e-05	0.00172	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GHRL—ulcerative colitis	2.65e-05	0.0017	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PTGER4—ulcerative colitis	2.63e-05	0.00169	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRB2—ulcerative colitis	2.58e-05	0.00165	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.51e-05	0.00161	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL20—ulcerative colitis	2.47e-05	0.00158	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.47e-05	0.00158	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.46e-05	0.00158	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GHRL—ulcerative colitis	2.45e-05	0.00157	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCR1—ulcerative colitis	2.44e-05	0.00157	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.42e-05	0.00155	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GHRL—ulcerative colitis	2.41e-05	0.00155	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCR1—ulcerative colitis	2.4e-05	0.00154	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CALM3—ulcerative colitis	2.38e-05	0.00152	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRB2—ulcerative colitis	2.34e-05	0.0015	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	2.33e-05	0.0015	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GNA12—ulcerative colitis	2.32e-05	0.00149	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	2.24e-05	0.00143	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCR2—ulcerative colitis	2.2e-05	0.00141	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCL8—ulcerative colitis	2.2e-05	0.00141	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	2.2e-05	0.00141	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.19e-05	0.00141	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADCY5—ulcerative colitis	2.19e-05	0.0014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	2.15e-05	0.00138	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	2.11e-05	0.00135	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR6—ulcerative colitis	2.07e-05	0.00133	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	2.03e-05	0.0013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	2.02e-05	0.00129	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	1.99e-05	0.00128	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADCY5—ulcerative colitis	1.99e-05	0.00127	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	1.98e-05	0.00127	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAML2—ulcerative colitis	1.96e-05	0.00126	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	1.91e-05	0.00123	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.91e-05	0.00123	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.9e-05	0.00122	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.9e-05	0.00122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	1.88e-05	0.0012	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	1.88e-05	0.0012	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.86e-05	0.0012	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTGER4—ulcerative colitis	1.82e-05	0.00117	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	1.8e-05	0.00115	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	1.77e-05	0.00113	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.72e-05	0.00111	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	1.71e-05	0.00109	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	1.69e-05	0.00109	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	1.67e-05	0.00107	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GHRL—ulcerative colitis	1.67e-05	0.00107	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CALM3—ulcerative colitis	1.62e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RIPK2—ulcerative colitis	1.59e-05	0.00102	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	1.58e-05	0.00102	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	1.55e-05	0.000997	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	1.45e-05	0.00093	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	1.42e-05	0.000913	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	1.4e-05	0.0009	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	1.38e-05	0.000887	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	1.38e-05	0.000886	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	1.38e-05	0.000884	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	1.36e-05	0.000874	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	1.36e-05	0.000871	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	1.24e-05	0.000798	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	1.24e-05	0.000794	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	1.2e-05	0.000769	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	1.19e-05	0.000762	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	1.18e-05	0.000759	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	1.18e-05	0.000756	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	1.17e-05	0.000752	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	1.16e-05	0.000745	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	1.13e-05	0.000724	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.08e-05	0.000693	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	1.08e-05	0.000692	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	1.08e-05	0.000689	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.06e-05	0.00068	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	1.06e-05	0.000677	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	1.03e-05	0.000662	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	1.02e-05	0.000653	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	1.01e-05	0.00065	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	1e-05	0.000641	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	9.81e-06	0.000629	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	9.63e-06	0.000618	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	9.38e-06	0.000601	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	9.21e-06	0.00059	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	7.31e-06	0.000469	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	7.08e-06	0.000454	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	6.67e-06	0.000428	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	6.38e-06	0.000409	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	6.35e-06	0.000407	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	6.35e-06	0.000407	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	6.24e-06	0.0004	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	6.15e-06	0.000394	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RELA—ulcerative colitis	6.04e-06	0.000387	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	6.04e-06	0.000387	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	5.97e-06	0.000383	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	5.8e-06	0.000372	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	5.69e-06	0.000365	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	5.54e-06	0.000355	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	5.51e-06	0.000353	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL2—ulcerative colitis	5.44e-06	0.000349	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	5.41e-06	0.000347	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	5.37e-06	0.000344	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	5.24e-06	0.000336	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	5.19e-06	0.000333	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	5.15e-06	0.00033	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	5.09e-06	0.000327	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	4.98e-06	0.000319	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	4.66e-06	0.000299	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	4.58e-06	0.000293	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	4.32e-06	0.000277	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	4.24e-06	0.000272	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	4.1e-06	0.000263	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	3.75e-06	0.00024	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	3.56e-06	0.000228	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TP53—ulcerative colitis	3.49e-06	0.000224	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	3.26e-06	0.000209	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—ulcerative colitis	3.2e-06	0.000205	CbGpPWpGaD
